1.Expert Consensus on Clinical Application of Qinbaohong Zhike Oral Liquid in Treatment of Acute Bronchitis and Acute Attack of Chronic Bronchitis
Jian LIU ; Hongchun ZHANG ; Chengxiang WANG ; Hongsheng CUI ; Xia CUI ; Shunan ZHANG ; Daowen YANG ; Cuiling FENG ; Yubo GUO ; Zengtao SUN ; Huiyong ZHANG ; Guangxi LI ; Qing MIAO ; Sumei WANG ; Liqing SHI ; Hongjun YANG ; Ting LIU ; Fangbo ZHANG ; Sheng CHEN ; Wei CHEN ; Hai WANG ; Lin LIN ; Nini QU ; Lei WU ; Dengshan WU ; Yafeng LIU ; Wenyan ZHANG ; Yueying ZHANG ; Yongfen FAN
Chinese Journal of Experimental Traditional Medical Formulae 2025;31(4):182-188
The Expert Consensus on Clinical Application of Qinbaohong Zhike Oral Liquid in Treatment of Acute Bronchitis and Acute Attack of Chronic Bronchitis (GS/CACM 337-2023) was released by the China Association of Chinese Medicine on December 13th, 2023. This expert consensus was developed by experts in methodology, pharmacy, and Chinese medicine in strict accordance with the development requirements of the China Association of Chinese Medicine (CACM) and based on the latest medical evidence and the clinical medication experience of well-known experts in the fields of respiratory medicine (pulmonary diseases) and pediatrics. This expert consensus defines the application of Qinbaohong Zhike oral liquid in the treatment of cough and excessive sputum caused by phlegm-heat obstructing lung, acute bronchitis, and acute attack of chronic bronchitis from the aspects of applicable populations, efficacy evaluation, usage, dosage, drug combination, and safety. It is expected to guide the rational drug use in medical and health institutions, give full play to the unique value of Qinbaohong Zhike oral liquid, and vigorously promote the inheritance and innovation of Chinese patent medicines.
2.Effects of different activators on platelet-rich plasma growth factors
Jianxiang LIU ; Xingxing FENG ; Shuxia WANG ; Rong ZHOU ; Mengxing LYU ; Kexuan QU
Chinese Journal of Tissue Engineering Research 2025;29(10):2067-2073
BACKGROUND:Growth factor is the key effect molecule that plays a role in platelet-rich plasma in clinical treatment.There are differences in the concentration of growth factor after different activators activate platelet-rich plasma,which is an important factor affecting clinical efficacy. OBJECTIVE:To analyze the influence of different activators on the mass concentration of growth factors in platelet-rich plasma. METHODS:Totally 12 healthy volunteers were recruited to collect EDTA-K2 anticoagulant venous blood.Secondary centrifugation was used to prepare platelet-rich plasma.The difference in mass concentrations of growth factors was compared between venous blood and platelet-rich plasma.The platelet-rich plasma was mixed with four activators(normal saline,thrombin,calcium gluconate,calcium gluconate+thrombin)according to the volume ratio of 10:1,and incubated in a constant temperature water bath at 37 °C for 30 minutes.After centrifugation,the supernatant was extracted and the mass concentration of growth factor was detected.The bacterial growth in supernatant was measured by blood agar plate.Pearson correlation was used to analyze the correlation between different activators and the mass concentration of growth factor in platelet-rich plasma,and the correlation between the value of thrombocytometer and the mass concentration of growth factors in platelet-rich plasma. RESULTS AND CONCLUSION:(1)The mass concentrations of platelet-derived growth factor-BB,platelet-derived growth factor-AB,vascular endothelial growth factor,and epidermal growth factor in platelet-rich plasma were 8.7,22.2,2.3,and 2.8 times of those in venous blood,respectively(P<0.05).(2)Compared with normal saline group,the mass concentrations of platelet-derived growth factor BB,platelet-derived growth factor AB,vascular endothelial growth factor,and epidermal growth factor were increased in the thrombin group,calcium gluconate group,and calcium gluconate+thrombin group(P<0.05).The mass concentration of platelet-derived growth factor BB in the thrombin group and calcium gluconate group was higher than that in the calcium gluconate+thrombin group(P<0.05),and the mass concentration of platelet-derived growth factor AB in the thrombin group was higher than that in the calcium gluconate group and calcium gluconate+thrombin group(P<0.05).Epidermal growth factor mass concentration in the thrombin group was lower than that in the calcium gluconate group and calcium gluconate+thrombin group(P<0.05).(3)The results of blood agar plate test showed no bacterial growth in the supernatant of the four groups.(4)Pearson correlation analysis showed that the mass concentration of platelet-derived growth factor BB in platelet-rich plasma was strongly positively correlated with thrombin(r=0.683,P<0.05),and the mass concentration of vascular endothelial growth factor was strongly positively correlated with thrombin,calcium gluconate,calcium gluconate+thrombin stimulant(r=0.730,0.789,0.686,P<0.05).There was no correlation between the value of thrombocytometer and the mass concentration of four kinds of growth factors(P>0.05).(5)The results suggest that different activators have an impact on the concentration of growth factors in platelet-rich plasma.It is suggested to choose different activators to improve clinical efficacy according to different growth factor mass concentrations and treatment needs.
3.Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
Meng SHA ; Jun WANG ; Jie CAO ; Zhi-Hui ZOU ; Xiao-ye QU ; Zhi-feng XI ; Chuan SHEN ; Ying TONG ; Jian-jun ZHANG ; Seogsong JEONG ; Qiang XIA
Clinical and Molecular Hepatology 2025;31(Suppl):S285-S300
Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated death globally. Liver transplantation (LT) has emerged as a key treatment for patients with HCC, and the Milan criteria have been adopted as the cornerstone of the selection policy. To allow more patients to benefit from LT, a number of expanded criteria have been proposed, many of which use radiologic morphological characteristics with larger and more tumors as surrogates to predict outcomes. Other groups developed indices incorporating biological variables and dynamic markers of response to locoregional treatment. These expanded selection criteria achieved satisfactory results with limited liver supplies. In addition, a number of prognostic models have been developed using clinicopathological characteristics, imaging radiomics features, genetic data, and advanced techniques such as artificial intelligence. These models could improve prognostic estimation, establish surveillance strategies, and bolster long-term outcomes in patients with HCC. In this study, we reviewed the latest findings and achievements regarding the selection criteria and post-transplant prognostic models for LT in patients with HCC.
4.Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
Meng SHA ; Jun WANG ; Jie CAO ; Zhi-Hui ZOU ; Xiao-ye QU ; Zhi-feng XI ; Chuan SHEN ; Ying TONG ; Jian-jun ZHANG ; Seogsong JEONG ; Qiang XIA
Clinical and Molecular Hepatology 2025;31(Suppl):S285-S300
Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated death globally. Liver transplantation (LT) has emerged as a key treatment for patients with HCC, and the Milan criteria have been adopted as the cornerstone of the selection policy. To allow more patients to benefit from LT, a number of expanded criteria have been proposed, many of which use radiologic morphological characteristics with larger and more tumors as surrogates to predict outcomes. Other groups developed indices incorporating biological variables and dynamic markers of response to locoregional treatment. These expanded selection criteria achieved satisfactory results with limited liver supplies. In addition, a number of prognostic models have been developed using clinicopathological characteristics, imaging radiomics features, genetic data, and advanced techniques such as artificial intelligence. These models could improve prognostic estimation, establish surveillance strategies, and bolster long-term outcomes in patients with HCC. In this study, we reviewed the latest findings and achievements regarding the selection criteria and post-transplant prognostic models for LT in patients with HCC.
5.Criteria and prognostic models for patients with hepatocellular carcinoma undergoing liver transplantation
Meng SHA ; Jun WANG ; Jie CAO ; Zhi-Hui ZOU ; Xiao-ye QU ; Zhi-feng XI ; Chuan SHEN ; Ying TONG ; Jian-jun ZHANG ; Seogsong JEONG ; Qiang XIA
Clinical and Molecular Hepatology 2025;31(Suppl):S285-S300
Hepatocellular carcinoma (HCC) is a leading cause of cancer-associated death globally. Liver transplantation (LT) has emerged as a key treatment for patients with HCC, and the Milan criteria have been adopted as the cornerstone of the selection policy. To allow more patients to benefit from LT, a number of expanded criteria have been proposed, many of which use radiologic morphological characteristics with larger and more tumors as surrogates to predict outcomes. Other groups developed indices incorporating biological variables and dynamic markers of response to locoregional treatment. These expanded selection criteria achieved satisfactory results with limited liver supplies. In addition, a number of prognostic models have been developed using clinicopathological characteristics, imaging radiomics features, genetic data, and advanced techniques such as artificial intelligence. These models could improve prognostic estimation, establish surveillance strategies, and bolster long-term outcomes in patients with HCC. In this study, we reviewed the latest findings and achievements regarding the selection criteria and post-transplant prognostic models for LT in patients with HCC.
6.Research progress on natural products regulating osteogenic differentiation
Hu CAI ; Xiaoqian WU ; Lingfei HAN ; Feng FENG ; Wei QU ; Wenyuan LIU
Journal of China Pharmaceutical University 2025;56(1):10-21
As the important source of bone cells, osteoblasts are involved in bone formation and repair, and play a key role in maintaining bone balance. If the osteogenic differentiation process in vivo is disrupted, a variety of bone-related diseases may occur. Natural products, which have a wide range of sources, a wide variety of physiological activities, and few toxic side-effects, have been found in recent years to be able to regulate osteoblast differentiation. Based on the sources of natural products, this paper reviews the intervention of natural products from plant, animal and microbial sources on osteogenic differentiation, aiming to provide a theoretical basis for natural products in the treatment of bone diseases.
7.Effects of Huaier polysaccharides on proliferation,apoptosis and angiogenesis of lung cancer cells by regulation of Shh-Gli1 signaling pathway
The Chinese Journal of Clinical Pharmacology 2024;40(7):990-993
Objective To investigate the effects of Huaier polysaccharides on proliferation,apoptosis,and angiogenesis in A549 cells by regulating the Sonic hedgehog-Gli family zinc finger 1(Shh-Gli1)signaling pathway.Methods A549 cells were divided into control group(normal culture)and low,medium,high dose experimental groups(2,5,and 10 μg·mL-1 Huaier polysaccharides).After 24 h of treatment,cell proliferation level was detected by methyl thiazolyl tetrazolium assay,cell apoptosis level was detected by flow cytometry,cysteine aspartic acid specific protease-3(caspase-3)enzyme activity in cells was detected by colorimetric assay,and the expression levels of vascular endothelial growth factor(VEGF),vascular endothelial growth factor receptor 2(VEGFR2),Shh and Gli1 proteins in cells were detected by Western blot.Results The cell survival rates of control group and low,medium,high dose experimental groups were 100.00%,(73.13±3.86)%,(47.97±6.12)%and(30.73±6.67)%,respectively;cell apoptosis rates were(0.72±0.04)%,(19.21±1.27)%,(29.48±0.92)%and(46.29±2.81)%,respectively;caspase-3 enzyme activity in cells were 1.00,1.33±0.08,1.71±0.09 and 2.28±0.14,respectively;the relative expression levels of VEGF protein in cells were 1.17±0.04,0.95±0.08,0.39±0.04 and 0.11±0.03,respectively;the relative expression levels of VEGFR2 protein in cells were 0.99±0.04,0.80±0.03,0.29±0.03 and 0.24±0.03,respectively;the relative expression levels of Gli1 protein in cells were 1.22±0.04,1.07±0.04,0.60±0.04 and 0.41±0.05,respectively.There were statistical significance of above indicators between control group and low,medium,high dose experimental groups(all P<0.05).Conclusion Huaier polysaccharides can inhibit proliferation and angiogenesis of A549 cells and promote apoptosis by regulating the Shh-Gli1 signaling pathway.
8.Protective effect of cryptotanshinone on premature ovarian insufficiency rats by regulating the SDF-1/CXCR4 axis
Zhun QU ; Huirong MA ; Dan FENG ; Dan CHOU ; Yu ZHANG ; Hongmei LI
China Pharmacy 2024;35(24):2998-3003
OBJECTIVE To investigate the protective effect of cryptotanshinone on premature ovarian insufficiency (POI) rats and its potential mechanism based on stromal cell-derived factor-1 (SDF-1)/CXC subfamily receptor 4 (CXCR4) axis. METHODS POI rat model was established by intraperitoneal injection of vinylcyclohexene (VCD). The successfully modeled rats were randomly divided into model group, cryptotanshinone low-dose group (50 mg/kg), cryptotanshinone high-dose group (100 mg/kg), and cryptotanshinone high-dose+AMD3100 group (100 mg/kg cryptotanshinone+2.5 mg/kg CXCR4 inhibitor AMD3100), with 10 rats in each group. Another 10 rats were injected with normal saline instead of VCD as the control group. Rats in each drug group were given intragastrical or (and) intraperitoneal injection of the corresponding drug once a day for 4 weeks. The levels of estradiol (E2), luteinizing hormone (LH) and follicle-stimulating hormone (FSH) in serum and reactive oxygen species (ROS), malondialdehyde (MDA), superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) in ovarian tissue were detected in each group. The morphology of ovarian tissue was observed. The cell apoptosis of ovarian tissue, as well as the mRNA expressions of SDF-1, CXCR4 and the protein expressions of caspase-3, B cell lymphoma-2 (Bcl-2), Bcl-2-associated X protein (Bax), SDF- 1, CXCR4 were detected. RESULTS Compared with the control group, the ovarian atrophied, the number of primitive follicles decreased, the number of atretic follicles increased, and the damage was obvious in the model group. Serum E2 level, SOD and GSH-Px levels in ovarian tissue, the mRNA expressions of SDF-1 and CXCR4, and the protein expressions of Bcl-2, SDF-1 and CXCR4 in ovarian tissue were all significantly decreased or down-regulated; the levels of FSH and LH in serum, ROS and MDA levels in ovarian tissue, the cell apoptosis rate, and the protein expressions of caspase-3 and Bax in ovarian tissue mail:k26awn@163.com were increased or upregulated significantly (P<0.05). Compared with model group, the ovarian tissue lesions of rats in cryptotanshinone low-dose and high-dose groups were significantly improved, and each quantitative index was significantly improved (P<0.05). AMD3100 could significantly reverse the improvement effect of cryptotanshinone on the above indexes (P<0.05). CONCLUSIONS Cryptotanshinone can reduce ovarian cell apoptosis and oxidative stress in POI rats by activating the SDF-1/CXCR4 axis, regulating serum hormone levels, thereby improving ovarian injury.
9.Research progress of TCM functional exercises for the treatment of fatigue
Yuying SHAO ; Jing LU ; Yuanyuan QU ; Chuwen FENG ; Shuhao GUO ; Binbin LI ; Tao CHEN ; Tiansong YANG
International Journal of Traditional Chinese Medicine 2024;46(1):119-123
TCM functional exercises are the important means of TCM to prevent and cure diseases. By adjusting the bones and muscles externally, adjusting the heart and organs internally, promoting blood circulation, improving sleep disorders, enhancing metabolism and immune capacity, the aim of preventing and treating diseases, prolonging life span, and strengthening the body is achieved. TCM exercises have a significant effect on the treatment of various types of fatigue such as chronic fatigue syndrome, Exercise-induced fatigue, post-stroke fatigue, and cancer-related fatigue.
10.Exploring the Ideas of Traditional Chinese Medicine in the Prevention and Treatment of Tumour Metastasis Exacerbated by Chronic Stress:from the Perspective of Abnormal Tumour Cell Adhesion
Fan ZHAO ; Gang YIN ; Feng TAN ; Fang WEN ; Rong QU ; Decai TANG
Journal of Traditional Chinese Medicine 2024;65(9):898-903
Abnormal tumour cell adhesion is a key step in tumour metastasis, in which weakened homologous and enhanced heterologous adhesion of tumour cells is an important cause of tumour metastasis. Chronic stress can activate the sympathetic nervous system to link and regulate the homologous and heterologous adhesion of tumour cells and exacerbate tumour metastasis. Combining the understanding of traditional Chinese medicine (TCM) and Western medicine on tumour metastasis, it is believed that the mechanism of "qi constraint and stagnation, tumor toxin transmission and retention" in TCM theory is highly related to the abnormal adhesion of tumour cells triggered by chronic stress. Qi constraint and stagnation is closely related to chronic stress and its activation of the sympathetic nervous system, and transmission and retention of tumor toxin explained the mechanism of tumour metastasis due to abnormal adhesion of tumour cells from the perspective of TCM. By regulating the key link of sympathetic nervous system-tumour cell adhesion, application of the formulas of regulating qi and resolving toxin can improve chronic stress and inhibit tumour metastasis.

Result Analysis
Print
Save
E-mail